DRUG · Mapped RxNorm record
Cyclophosphamide
Normalized identity: cyclophosphamideView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid Tumors
NCT02650635
Drugs and interventions used in this trial
5 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
OTHER · Unmapped registry intervention
Laboratory Biomarker Analysis
Find medicine records ·
Find other trials using this name
BIOLOGICAL · Unmapped registry intervention
Pegfilgrastim
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
Pharmacological Study
Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
TLR8 Agonist VTX-2337
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedTLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid Tumors
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Metastatic Pancreatic Adenocarcinomaunresolved
Recurrent Breast Carcinomaunresolved
Recurrent Colorectal Carcinomaunresolved
Recurrent Melanoma of the Skinunresolved
Recurrent Non-Small Cell Lung Carcinomaunresolved
Recurrent Pancreatic Carcinomaunresolved
Recurrent Renal Cell Carcinomaunresolved
Solid Neoplasmunresolved
Stage IV Breast Cancerunresolved
Stage IV Non-Small Cell Lung Cancerunresolved
Stage IV Renal Cell Cancerunresolved
Stage IV Skin Melanomaunresolved
Stage IVA Colorectal Cancerunresolved
Stage IVA Pancreatic Cancerunresolved
Stage IVB Colorectal Cancerunresolved
Stage IVB Pancreatic Cancerunresolved
Interventions
CyclophosphamideDRUG · verified · RxNorm: cyclophosphamide
PegfilgrastimBIOLOGICAL
Sponsors & collaborators
Mayo Cliniclead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02650635 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.